BioNeutra Global Corporation (Canada: TSX-V: BGA; US: OTCQB:BGACF) researches, develops and commercializes food ingredients for nutraceutical and mainstream food products. It is the only health ingredient manufacturer in Canada to leverage science-based processes into the commercial product marketplace.
BioNeutra is a leader in IMO technology and VitaFiber® IMO is recognized in Canada, USA. Europe, Australia and New Zealand. With the prebiotics industry at an emerging stage and revenue growth expected at 25% per year, BioNeutra can deliver significant shareholder value in this health super cycle.
Here are a few additional reasons to invest in BGA:
• Strong growth in revenue and cash flow
• Recent acquisition of production facility to ensure quality control
• Product leadership growing global demand
• Management team who can execute
Contact us today to learn more about the unique investment opportunity with BioNeutra.